Zynex (ZYXI) Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zynex in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ZYXI shares.
View ZYXI analyst ratings or view top-rated stocks.

3 brokerages have issued twelve-month price objectives for Zynex's stock. Their ZYXI share price forecasts range from $12.50 to $28.00. On average, they expect the company's stock price to reach $19.63 in the next year. This suggests a possible upside of 113.8% from the stock's current price.
View analysts price targets for ZYXI or view top-rated stocks among Wall Street analysts.

Zynex's stock was trading at $13.91 at the start of the year. Since then, ZYXI stock has decreased by 34.0% and is now trading at $9.18.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023.
View our ZYXI earnings forecast.

Zynex, Inc. (NASDAQ:ZYXI) posted its quarterly earnings data on Thursday, April, 27th. The company reported $0.04 EPS for the quarter, beating analysts' consensus estimates of $0.01 by $0.03. The business had revenue of $42.17 million for the quarter, compared to analyst estimates of $39.67 million. Zynex had a net margin of 10.19% and a trailing twelve-month return on equity of 26.02%.

ETFs with the largest weight of Zynex (NASDAQ:ZYXI) stock in their portfolio include Invesco S&P SmallCap 600 Pure Growth ETF (RZG), Hartford Multifactor Small Cap ETF (ROSC), First Trust Dow Jones Select Microcap Index Fund (FDM), Syntax Stratified SmallCap ETF (SSLY), Invesco DWA SmallCap Momentum ETF (DWAS), Barrons 400 ETF (BFOR), Invesco S&P SmallCap Health Care ETF (PSCH) and Invesco S&P SmallCap Momentum ETF (XSMO).

Zynex issued an update on its first quarter 2023 earnings guidance on Tuesday, May, 2nd. The company provided EPS guidance of 0-$0.03 for the period, compared to the consensus earnings per share estimate of $0.01. The company issued revenue guidance of $39.00 million-$41.00 million, compared to the consensus revenue estimate of $39.61 million.

81 employees have rated Zynex Chief Executive Officer Thomas Sandgaard on Glassdoor.com. Thomas Sandgaard has an approval rating of 87% among the company's employees.

Zynex trades on the NASDAQ under the ticker symbol "ZYXI."

Zynex's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.28%), State Street Corp (1.87%), Geode Capital Management LLC (1.19%), Anson Funds Management LP (0.00%), Anson Funds Management LP (0.00%) and Bank of New York Mellon Corp (0.74%). Insiders that own company stock include Anna Lucsok, Daniel J Moorhead and Thomas Sandgaard.
View institutional ownership trends.

Shares of ZYXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ZYXI stock can currently be purchased for approximately $9.18.

Zynex (NASDAQ:ZYXI) has a market capitalization of $336.45 million and generates $158.17 million in revenue each year. The company earns $17.05 million in net income (profit) each year or $0.45 on an earnings per share basis.

The company employs 774 workers across the globe.

Zynex's mailing address is 9555 MAROON CIRCLE, ENGLEWOOD CO, 80112. The official website for the company is www.zynex.com. The company can be reached via phone at (303) 703-4906 or via email at info@zynex.com.